CBD oil can improve the treatments and conditions for life-threatening liver diseases. The human body has natural cannabinoid receptors known as CB (1), which are located in the brain and central nervous system and CB (2), which are found on cells throughout the immune system. This complete makeup is known as the endocannabinoid system. The ECS is a system composed of endocannabinoids, which are endogenous lipid-based retrograde neurotransmitters that bind to cannabinoid receptors, and cannabinoid receptor proteins that are expressed throughout the central nervous system (including the brain and peripheral nervous system). The endocannabinoid system is involved in regulating a variety of physiological and cognitive processes including fertility, pregnancy, lack of appetite, dealing with pain, mood and memory, and in mediating the pharmacological effects of cannabis. These receptors bind to the CBD molecules and create a set of reactions that are beneficial for our body’s processes, although how this happens is not fully understood by researchers.
When it comes to CBD and liver diseases, researchers discovered that the EC system, mentioned earlier, is not on when the liver is healthy. But, once a chronic liver disease is detected, the EC system is triggered, being part of the pathogenesis of a series of liver conditions, such as non-alcoholic fatty liver disease, fibrosis progressing to cirrhosis, and appearance of cardiovascular abnormalities developed by the presence of cirrhosis. Also, in case of an injury to the liver, the EC is responsible for some of the inflammatory reactions and controls the mechanism that manage cell rejuvenation; this is why it is thought that CBD has great chances of success when it comes to healing liver diseases.